| P/E (FY) | — | Sales (TTM) | €5.24B |
| Earnings (TTM) | -€54.1M | ROE | −4.62% |
| Net Margin | −1.03% | ROIC | — |
| Debt / Equity | 1.66 | TD / EBITDA | 3.13 |
| EPS Growth 3Y | — | Sales Growth 3Y | 6.82% |
Ramsay Generale de Sante operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It runs medical centers and mental health day care centers in France and provides services spanning medicine, surgery and obstetrics, dialysis, oncology, medical imaging, rehabilitation, geriatrics, home hospitalization, mental health and addiction treatment, maternity, and emergency care. A subsidiary of Ramsay Health Care Limited, the company is headquartered in Paris, France.
| Market Cap | $1.35B | Trading Days | 4173 |
| 52W High | 11.55 |
| 52W Low | 8.72 |
| % Off High | −6.93% |
| YTD | 15.84% | 1Y | 1.90% |
| 3Y | −50.91% | 5Y | −42.05% |
| 10Y | −14.19% | Since incept. (ann.) | 1.77% |
| Ann. Volatility (1Y) | 25.87% | Ann. Volatility (3Y) | 30.26% |
| Sharpe (1Y) | 0.20 | Sharpe (3Y) | −0.69 |
| Max Drawdown (1Y) | −16.59% | Max Drawdown (3Y) | −60.54% |
| Beta (3Y, vs SPY) | 0.24 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | $1.35B | — |
| AORT | ARTIVION, INC. | $1.34B | 131.2 |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.33B | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | $1.33B | — |
| ETON | Eton Pharmaceuticals, Inc. | $1.32B | — |
| AVBP | ArriVent BioPharma, Inc. | $1.40B | — |
| ELN.MI | EL.EN. - S.P.A. | $1.41B | 29.0 |
| CNMD | CONMED Corp | $1.29B | 28.6 |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.28B | — |
| PNTG | Pennant Group, Inc. | $1.43B | 48.9 |
| CDRE | Cadre Holdings, Inc. | $1.43B | 32.7 |
| TNDM |
| TANDEM DIABETES CARE INC |
| $1.27B |
| — |
